Donna LaVoie
@dlavoie02Founder, LaVoieHealthScience, a team of specialized thinkers and communicators for the health and science industry @Forbes Contributor, https://t.co/EDxAG6P4D6
Similar User
@FierceBiotech
@IPREX_Global
@cafepharma
@LifeSciAdvisors
@PharmaScrip
@LaVoieGroup
@demy_sara
@BobCoughlin
@marksmithvr
@crisdeluca
@BioPharmaJosh
@BiotechStockRsr
@kimberlyanngeo
@GregoryTSimpson
#bio2023 Why are you here? Meet your audience with your story @LaVoieGroup linkedin.com/posts/donnalla…
This month, we celebrate 23 years of bridging health and science brands from inception to commercialization. For over two decades, LHS has proudly partnered with innovative companies to bring groundbreaking technologies to market. From the early days of monoclonal antibodies to…
Donna LaVoie, our CEO, was recently interviewed on the @PRWeekUS podcast with host Steve Barrett and co-host Frank Washkuch. In this episode, they discuss the nuances of public relations in heavily regulated industries, navigating crisis communications, and what the year ahead…
Honored to have George Church in the podcast studio today. This episode will air on Tuesday. 30+ minutes of his take on the latest in science, startups, and the future. Interviewed by @dj_mandell
.@Tonixpharma has a Mpox candidate vaccine in the works. CEO Dr. Seth Lederman joined Bloomberg Open Interest to talk about how concerned people should be about the outbreak trib.al/YA7dnPg
Healthcare, health-tech + life sciences are evolving at breakneck speed. How do you keep up? Tune into my new podcast “Second Opinion” podcast where my co-hosts @chrissyfarr and @azenooz and I cut through the noise and spotlight the next big wins in health-tech. From #biotech…
📢 Registration is open for #BIF24! Join us in San Francisco for the BIO Investor Forum on Oct 15-16. Enjoy panel discussions, Company Presentations, and BIO One-on-One Partnering™ meetings. Register now for Early Bird rates: bif.bio.org/registration
From our team to yours, Happy Independence Day! We wish everyone a happy and safe holiday! #IndependenceDay #4thofJuly
Urinary disease biotech Jyong Biotech refiles for a $29 million US IPO $JBIO.RC $IPO #IPO buff.ly/3PbEyHX
Next winner: Menarin Group and LaVoie Health Science!
Our first-ever virtual #genetherapy R&D Day on April 17 will highlight progress across our proprietary non-viral gene insertion and editing technologies plus new #preclinical data and more. Details here: wsw.com/webcast/cc/pst… #CapacitytoCure $PSTX
Thanks to the Workforce Training Grant, we have completed Emotional Intelligence training and have started presentation training led by Elise Simard, an employee development and corporate trainer with an extensive background in broadcast production and business development. LHS…
Recently, our President and CEO John F. Crowley sat down with the hosts of the In Sickness Podcast, which highlights stories of extraordinary men in caregiver culture. Listen to John’s heroic story and what he accomplished against unimaginable odds here: insickness.org/podcast/episod…
Last week, Carver High School visited GRObio! Our lab experience reinforced their classroom learning in #synthetic biology. We introduced unconventional career paths from our scientists, sparking their passion for #STEM. Here's to inspiring the next generation of #innovators!…
Biotech seniors and teachers were invited to tour the GRO Biosciences facility in Cambridge with the founder of the pharmaceutical company and several scientists. Sudents even got to test out their skills. Thank you to GRO Biosciences for this amazing bit.ly/3QKWG9u
Just out: Detecting phosphorylated alpha-synuclein through cutaneous nerves is a more convenient pathway than other tests requiring spinal fluid or nuclear medicine imaging businesswire.com/news/home/2024… @LaVoieGroup
My latest for @BW: Gene therapy could be the future of medicine, potentially curing many diseases. But some drugmakers have found that scientific achievement doesn’t guarantee financial success. bloomberg.com/news/articles/…
In honor of Valentine’s Day, @OldNorth1723 is celebrating some of their favorite couples from their history! ❤️🔔 youtu.be/LWZAYVU53S8?si…
LHS is honored to be a Gold Winner of the 2024 AVA Digital Awards for our recent #websiteredesign. Our goal was to convey our position as a specialized agency partnering with clients across the health science spectrum, from early clinical stages to global commercial endeavors.…
LaVoieHealthScience names Dodge Boston GM prweek.com/article/186082… via @prweek
In the world of #PR for #lifesciences, one of our core philosophies is dedicating senior talent, coupled with strong executional support to our clients. Our seasoned experts bring a wealth of experience and strategic insights into the #healthcommunication space to drive success…
United States Trends
- 1. Georgia 249 B posts
- 2. Haynes King 11,7 B posts
- 3. Kirby 26,2 B posts
- 4. #GoDawgs 11,9 B posts
- 5. Bob Bryar 11,4 B posts
- 6. 8 OTs 2.068 posts
- 7. Nebraska 17,3 B posts
- 8. GA Tech 4.097 posts
- 9. 8th OT 1.020 posts
- 10. Iowa 25,9 B posts
- 11. Athens 10,4 B posts
- 12. Carson Beck 4.502 posts
- 13. Brent Key 1.894 posts
- 14. Reaves 4.293 posts
- 15. Joe Tessitore 1.993 posts
- 16. #GTvsUGA 1.106 posts
- 17. Targeting 78,5 B posts
- 18. Dan Jackson 2.787 posts
- 19. #MMA2024 33,3 B posts
- 20. Arian Smith 1.847 posts
Who to follow
-
FierceBiotech
@FierceBiotech -
IPREX
@IPREX_Global -
cafepharma
@cafepharma -
LifeSci Advisors
@LifeSciAdvisors -
Scrip, Citeline Commercial
@PharmaScrip -
LaVoieHealthScience
@LaVoieGroup -
Sara Jane Demy
@demy_sara -
Bob Coughlin
@BobCoughlin -
Mark Smith
@marksmithvr -
Cris De Luca
@crisdeluca -
Josh Berlin
@BioPharmaJosh -
BiotechStockResearch
@BiotechStockRsr -
Kimberly George
@kimberlyanngeo -
Gregory T Simpson
@GregoryTSimpson
Something went wrong.
Something went wrong.